These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia. Snelling TL; Andrews RM; Kirkwood CD; Culvenor S; Carapetis JR Clin Infect Dis; 2011 Jan; 52(2):191-9. PubMed ID: 21288843 [TBL] [Abstract][Full Text] [Related]
10. Report of the Australian rotavirus surveillance program 2002-03. Kirkwood CD; Bogdanovic-Sakran N; Clark R; Bishop RF; Barnes GL Commun Dis Intell Q Rep; 2003; 27(4):492-5. PubMed ID: 15508503 [TBL] [Abstract][Full Text] [Related]
12. Bug breakfast in the bulletin: rotavirus. Corner HL; McCartney K; Hazelton B N S W Public Health Bull; 2011 Jun; 22(3-4):88. PubMed ID: 21632006 [No Abstract] [Full Text] [Related]
13. United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction. Hull JJ; Teel EN; Kerin TK; Freeman MM; Esona MD; Gentsch JR; Cortese MM; Parashar UD; Glass RI; Bowen MD; Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S42-7. PubMed ID: 21183839 [TBL] [Abstract][Full Text] [Related]
14. Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. Bresee JS; Hummelman E; Nelson EA; Glass RI J Infect Dis; 2005 Sep; 192 Suppl 1():S1-5. PubMed ID: 16088790 [No Abstract] [Full Text] [Related]